Supplementary Information Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
Arg methylase inhibitors (AMIs), symmetric sulfonated urea, specifically inhibit PRMT activity and, in a rat model, cyclooxygenase-2 (COX-2) expression and suppress inflammation
Ruan et al., 2020
BPC-157 and PRP are increasingly used together in regenerative medicine, and the logic is sound
In about 70% of people, the first symptoms appear in the limbs usually starting with hand weakness (60%) or leg weakness (40%)
Diagnosis of dn-AIH is made following exclusion of all other causes of graft dysfunction, including cellular and antibody-mediated rejection
